Align Technology announced that the U.S. Food and Drug Administration has cleared Align’s Invisalign Palatal Expander System for commercial availability in the U.S. The FDA 510(k) clearance is for broad patient applicability, including growing children, teens, and adults.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ALGN:
- Early notable gainers among liquid option names on December 14th
- Health Canada issues updated medical device license for Align’s Palatal Expander
- Nike upgraded, Paramount downgraded: Wall Street’s top analyst calls
- Nasdaq announces annual changes to Nasdaq-100 Index
- Align Technology just downgraded at Goldman Sachs, here’s why
